My Cart

Human / Cynomolgus Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc)

  • Related Products: Bridging ELISA Kit BIS-A004
Customer Reviews
Cat. No. / Size
Price
Qty
CL2-H5586-20ug
$1440.00
CL2-H5586-100ug
$5355.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Cell based assay (FACS or functional assay)
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    Claudin-18.2, CLDN18, Claudin-18

  • Source

    Nanodisc Human / Cynomolgus Claudin-18.2, His,Twin-Strep Tag (CL2-H5586) is expressed from Baculovirus-Insect cells. It contains AA Met 1 - Ala 200 (Accession # P56856-2). In the region Met 1 - Ala 200, the amino acid sequences of Human and Cynomolgus Claudin-18.2 are identical.

    Predicted N-terminus: Met

    Request for sequence

  • Molecular Characterization

    Claudin-18.2 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the N-terminus and a twin strep tag at the C-terminus.

    The protein has a calculated MW of 26.5 kDa.

    *The isotype control of empty/mock nanodisc (Cat. No. APO-H51H3) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Nanodisc membrane protein is wrapped by a synthetic phospholipid bilayer membrane structure, composed of membrane scaffold proteins (MSPs) and phospholipids.

    2. Synthesis Process

      Nanodisc reconstitution is a self-assembly process that starts from purified, detergent-solubilized membrane proteins and reconstitutes them into synthetic phospholipid bilayers stabilized by MSP1D1 membrane scaffold protein. This creates a stable, detergent-free environment that preserves native conformation and biological activity, with excellent homogeneity and full compatibility with cell-based assays such as FACS and binding assays in antibody discovery and screening (ELISA),etc.

  • Formulation

    Supplied as 0.2 μm filtered solution in 20 mM HEPES, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     Claudin-18.2 ELISA

    Immobilized Human / Cynomolgus Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5586) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 with a linear range of 0.1-2 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     Claudin-18.2 SPR

    Monoclonal Anti-Chimeric Claudin-18.2 Antibody, Human IgG1 captured on Protein A Chip can bind Human / Cynomolgus Claudin-18.2, His,Twin-Strep Tag (Cat. No. CL2-H5586) with an affinity constant of 12.6 nM as determined in SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-FACS

     Claudin-18.2 FACS

    2e5 of Anti-Claudin18.2 CAR-293 cells were stained with 100 μL of 3 μg/mL Human Claudin-18.2 Protein, His,Twin-Strep Tag (Nanodisc)(Cat. No. CL2-H5586) and isotype control protein respectively, washed and then followed by PE anti-His Tag Antibody and analyzed with FACS (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

A tight junction protein normally confined to gastric mucosa but exposed on tumor cell surfaces during malignant transformation. It is a premier target in gastric and pancreatic adenocarcinoma, with the monoclonal antibody zolbetuximab demonstrating significant survival benefit in CLDN18.2-positive advanced disease.

Recent Advances

 
Drug Development Progress
  • English Name:

    Claudin-18 splice variant 2

  • Category:

  • Approved Drugs:

    1 Details

  • Drugs in Clinical Trials:

    82 Details

  • Highest Development Stage:

    Approved

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland